INS and metabolic syndrome: Palmitoleic acid is associated with increased insulin concentrations [55] and resistance [56], [57], [58], [59], [60], [61], [62], type II diabetes [63], [64], metabolic syndrome [61], [65], [66], heart failure [67] and coronary heart disease [68].